118 related articles for article (PubMed ID: 28882766)
21. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
[TBL] [Abstract][Full Text] [Related]
22. Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogs.
Yang J; Kang Y; Wang B; Yang L; Liu J; Zhang W
Eur J Pharm Sci; 2017 Mar; 99():343-349. PubMed ID: 28057551
[TBL] [Abstract][Full Text] [Related]
23. Preclinical safety evaluation of ET-26 hydrochloride, a novel intravenous anesthetic agent, in beagle dogs.
Zhang Y; Deng C; Gong D; Kang Y; Liu J; Zhang W
J Appl Toxicol; 2020 May; 40(5):679-690. PubMed ID: 31867768
[TBL] [Abstract][Full Text] [Related]
24. Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1.
Matsuishi Y; Jesmin S; Kawano S; Hideaki S; Shimojo N; Mowa CN; Akhtar S; Zaedi S; Khatun T; Tsunoda Y; Kiwamoto T; Hizawa N; Inoue Y; Mizutani T
Life Sci; 2016 Dec; 166():27-33. PubMed ID: 27742253
[TBL] [Abstract][Full Text] [Related]
25. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Cotten JF; Husain SS; Forman SA; Miller KW; Kelly EW; Nguyen HH; Raines DE
Anesthesiology; 2009 Aug; 111(2):240-9. PubMed ID: 19625798
[TBL] [Abstract][Full Text] [Related]
26. The inhibiting effect of intravenous anesthesia on adrenal gland functions under the sepsis condition.
Wang T; Liu C; Wei P; Lv L; Yang Z
Int J Immunopathol Pharmacol; 2017 Jun; 30(2):188-193. PubMed ID: 28406323
[TBL] [Abstract][Full Text] [Related]
27. Etomidate Mitigates Lipopolysaccharide-Induced CD14 and TREM-1 Expression, NF-κB Activation, and Pro-inflammatory Cytokine Production in Rat Macrophages.
Liu M; Zhang Y; Xiong JY; Wang Y; Lv S
Inflammation; 2016 Feb; 39(1):327-335. PubMed ID: 26383906
[TBL] [Abstract][Full Text] [Related]
28. Deficiency of alpha-calcitonin gene-related peptide induces inflammatory responses and lethality in sepsis.
Lee JK; Jung JS; Park SH; Sim YB; Suh HW
Cytokine; 2013 Nov; 64(2):548-54. PubMed ID: 24021706
[TBL] [Abstract][Full Text] [Related]
29. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats.
Chu CH; David Liu D; Hsu YH; Lee KC; Chen HI
Pulm Pharmacol Ther; 2007; 20(5):503-12. PubMed ID: 16713316
[TBL] [Abstract][Full Text] [Related]
30. Effects of the anti-sepsis drug, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD-712), on mortality, inflammation, and organ injuries in rodent sepsis models.
Park JH; Hwang IC; Ha N; Lee S; Kim JM; Lee SS; Yu H; Lim IT; You JA; Kim DH
Arch Pharm Res; 2011 Mar; 34(3):485-94. PubMed ID: 21547682
[TBL] [Abstract][Full Text] [Related]
31. The pituitary adenylate cyclase-activating polypeptide (PACAP) protects adrenal function in septic rats administered etomidate.
Liu N; Zhang Y; Xiong JY; Liu S; Zhu J; Lv S
Neuropeptides; 2016 Aug; 58():53-9. PubMed ID: 27103538
[TBL] [Abstract][Full Text] [Related]
32. Effect of etomidate on adrenal function in rats.
Hampl R; Bicíková M; Motlík K; Stárka L
Endocrinol Exp; 1987 Sep; 21(3):229-35. PubMed ID: 3499308
[TBL] [Abstract][Full Text] [Related]
33. Endotoxin-induced acute lung injury and organ dysfunction are attenuated by pentobarbital anaesthesia.
Kao SJ; Su CF; Liu DD; Chen HI
Clin Exp Pharmacol Physiol; 2007; 34(5-6):480-7. PubMed ID: 17439419
[TBL] [Abstract][Full Text] [Related]
34. Propofol attenuates renal ischemia-reperfusion injury aggravated by hyperglycemia.
Yoo YC; Yoo KJ; Lim BJ; Jun JH; Shim JK; Kwak YL
J Surg Res; 2013 Aug; 183(2):783-91. PubMed ID: 23498343
[TBL] [Abstract][Full Text] [Related]
35. Etomidate--a review of robust evidence for its use in various clinical scenarios.
Erdoes G; Basciani RM; Eberle B
Acta Anaesthesiol Scand; 2014 Apr; 58(4):380-9. PubMed ID: 24588359
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite.
Ge RL; Pejo E; Haburcak M; Husain SS; Forman SA; Raines DE
Anesth Analg; 2012 Aug; 115(2):305-8. PubMed ID: 22052979
[TBL] [Abstract][Full Text] [Related]
37. Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the Metabolite.
Pejo E; Liu J; Lin X; Raines DE
Anesth Analg; 2016 Apr; 122(4):1008-14. PubMed ID: 26991617
[TBL] [Abstract][Full Text] [Related]
38. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.
Husain SS; Pejo E; Ge R; Raines DE
Anesthesiology; 2012 Nov; 117(5):1027-36. PubMed ID: 22929736
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of endotoxin in a rat model of chronic inflammation are accompanied by suppressed secretion of pro-inflammatory cytokines and biphasic alteration in hypothalamo-pituitary-adrenal axis activity.
Richards LJ; Chover-Gonzalez A; Harbuz MS; Jessop DS
J Neuroendocrinol; 2006 Nov; 18(11):875-82. PubMed ID: 17026537
[TBL] [Abstract][Full Text] [Related]
40. Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.
McGrath M; Ma C; Raines DE
J Pharmacol Exp Ther; 2018 Feb; 364(2):229-237. PubMed ID: 29203576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
